Speciality: Pharmacist Tech
Location: London
Duration: Temporary
Speciality: Pharmacist
Location: Wales
Duration: Temporary
Speciality: Pharmacist Tech
Location: Wales
Duration: Temporary
Speciality: Pharmacist
Location: Wales
Duration: Temporary
Changes could be made to the way that rheumatoid arthritis medications are dispensed before patients undergo surgery.
Research presented at the annual meeting of the American College of Rheumatology has highlighted the fact that doctors have been stopping anti-TNF medications sooner than is necessary before surgery.
Investigators claim making improvements to the timings could minimise the risk of disease flares and that this is an area which warrants further study.
Dr Lisa Mandl, rheumatologist at the Hospital for Special Surgery, has suggested that adopting a pharmacologically-based timing system could reduce postoperative flares.
She said: "It doesn't look like there are any increases in infections or blood clots or other problems that go along with these anti-TNFs, which is comforting for patients who are on these drugs who are going in for surgery."
A recent study published in Nature Immunology has discovered a protein that is pro-inflammatory can actually suppress certain aspects of this reaction.
Posted by Mathew Horton
According to the National Migraine Centre, one in seven people around the globe are affected by migraines,...
The NHS has made a new offer to a drug company to provide medicine for potentially thousands of cystic fibrosis...
Spinal muscular atrophy (SMA) is a rare genetic disease that up until now has had no treatment for the underlying...
Primary progressive multiple sclerosis (PPMS) is a rare form of MS that affects less than 15 per cent of people...